JP2019511918A5 - - Google Patents

Download PDF

Info

Publication number
JP2019511918A5
JP2019511918A5 JP2018545182A JP2018545182A JP2019511918A5 JP 2019511918 A5 JP2019511918 A5 JP 2019511918A5 JP 2018545182 A JP2018545182 A JP 2018545182A JP 2018545182 A JP2018545182 A JP 2018545182A JP 2019511918 A5 JP2019511918 A5 JP 2019511918A5
Authority
JP
Japan
Prior art keywords
gene
rodent
tmprss
humanized
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018545182A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019511918A (ja
JP6980674B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/019574 external-priority patent/WO2017151453A1/en
Publication of JP2019511918A publication Critical patent/JP2019511918A/ja
Publication of JP2019511918A5 publication Critical patent/JP2019511918A5/ja
Application granted granted Critical
Publication of JP6980674B2 publication Critical patent/JP6980674B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018545182A 2016-02-29 2017-02-27 ヒト化tmprss遺伝子を有する齧歯類 Active JP6980674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662301023P 2016-02-29 2016-02-29
US62/301,023 2016-02-29
PCT/US2017/019574 WO2017151453A1 (en) 2016-02-29 2017-02-27 Rodents having a humanized tmprss gene

Publications (3)

Publication Number Publication Date
JP2019511918A JP2019511918A (ja) 2019-05-09
JP2019511918A5 true JP2019511918A5 (enExample) 2020-04-09
JP6980674B2 JP6980674B2 (ja) 2021-12-15

Family

ID=58264641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018545182A Active JP6980674B2 (ja) 2016-02-29 2017-02-27 ヒト化tmprss遺伝子を有する齧歯類

Country Status (14)

Country Link
US (5) US10070632B2 (enExample)
EP (2) EP3422845B1 (enExample)
JP (1) JP6980674B2 (enExample)
KR (2) KR102775366B1 (enExample)
CN (1) CN109068621B (enExample)
AU (1) AU2017228293B2 (enExample)
CA (1) CA3014645C (enExample)
DK (1) DK3422845T3 (enExample)
ES (1) ES2886958T3 (enExample)
IL (1) IL261139B (enExample)
PT (1) PT3422845T (enExample)
RU (1) RU2749715C2 (enExample)
SG (2) SG10202001578RA (enExample)
WO (1) WO2017151453A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6980674B2 (ja) 2016-02-29 2021-12-15 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. ヒト化tmprss遺伝子を有する齧歯類
ES2962277T3 (es) * 2017-09-29 2024-03-18 Regeneron Pharma Roedores que comprenden un locus Ttr humanizado y métodos de uso
SMT202100307T1 (it) 2018-01-26 2021-07-12 Regeneron Pharma Anticorpi e frammenti di legame di anti-tmprss2
HRP20240999T1 (hr) 2018-07-16 2024-10-25 Regeneron Pharmaceuticals, Inc. Glodavački modeli bolesti ditra i njihova upotreba
JP7509786B2 (ja) * 2019-01-17 2024-07-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 気分障害の齧歯類モデル
JP7772702B2 (ja) 2020-02-10 2025-11-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 抗tmprss2抗体および抗原結合断片
CN115161326B (zh) * 2021-06-21 2024-09-24 百奥赛图(北京)医药科技股份有限公司 Sost基因人源化非人动物及其构建方法和应用
US20250049006A1 (en) * 2021-12-20 2025-02-13 C/O Regeneron Pharmaceuticals, Inc. Non-human animals comprising humanized ace2 and tmprss loci
KR20250169390A (ko) * 2024-05-23 2025-12-03 한국화학연구원 인간 ace2 및 tmprss2 유전자를 발현하는 형질전환마우스와 이의 용도

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002065266A (ja) * 2000-08-28 2002-03-05 Teijin Ltd 気道特異的トリプシン様酵素およびその利用法
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
AU2002359781A1 (en) * 2001-12-20 2003-07-09 The Regents Of The University Of California Triple transgenic mouse model of alzheimer's disease
US20050026255A1 (en) * 2002-06-25 2005-02-03 Morser John Michael Corin, a serine protease
WO2004033630A2 (en) * 2002-10-04 2004-04-22 Schering Aktiengesellschaft Modified hepsin molecules having a substitute activation sequence and uses thereof
US7176013B2 (en) * 2003-06-11 2007-02-13 Schering Aktiengesellschaft Modified corin molecules having substitute activation sequences and uses thereof
US7491865B2 (en) * 2004-08-19 2009-02-17 Fred Hutchinson Cancer Research Center Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
ATE502951T1 (de) * 2006-05-23 2011-04-15 Irm Llc Verbindungen und zusammensetzungen als kanalaktivierende protease-hemmer
GB0821624D0 (en) * 2008-11-26 2008-12-31 Eisai London Res Lab Ltd Assay
EP3543256A1 (en) * 2009-01-12 2019-09-25 Cytomx Therapeutics Inc. Modified antibody compositions, methods of making and using thereof
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
CA3040377C (en) 2009-10-06 2025-12-30 Yale University Genetically modified mice and engraftment comprising the knock-in of a human thrombopoietin (tpo) gene
ES3040596T3 (en) * 2011-02-15 2025-11-03 Regeneron Pharma Humanized m-csf mice and uses thereof
RS56330B1 (sr) 2011-10-28 2017-12-29 Regeneron Pharma Genetski modifikovani miševi sa ekspresijom himernih molekula klase ii glavnog kompleksa histokompatibilnosti (mhc)
MY186903A (en) 2011-10-28 2021-08-26 Regeneron Pharma Humanized il-6 and il-6 receptor
RS56656B1 (sr) 2011-10-28 2018-03-30 Regeneron Pharma Miševi sa genetski modifikovanim glavnim kompleksom gena tkivne podudarnosti
CN104244978A (zh) 2012-04-16 2014-12-24 瑞泽恩制药公司 通过施用丝氨酸蛋白酶抑制剂治疗或预防流感病毒感染的方法
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
WO2013192550A2 (en) * 2012-06-22 2013-12-27 Cytomx Therapeutics, Inc. Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
KR102287541B1 (ko) 2012-09-07 2021-08-10 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
EP4389764B1 (en) 2012-11-05 2026-03-18 Regeneron Pharmaceuticals, Inc. Genetically modified rodents and methods of use thereof
AU2014218931C1 (en) 2013-02-20 2020-05-14 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
KR20240147707A (ko) 2013-02-20 2024-10-08 리제너론 파아마슈티컬스, 인크. 사람화된 t-세포 보조-수용체를 발현하는 마우스
CN110192541B (zh) 2013-02-22 2022-02-18 瑞泽恩制药公司 表达人源化主要组织相容性复合物的小鼠
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
CA2908697C (en) 2013-04-16 2023-12-12 Regeneron Pharmaceuticals, Inc. Targeted modification of rat genome
BR112015030514A2 (pt) 2013-06-04 2017-08-29 Cytomx Therapeutics Inc Composições e métodos para conjugação de anticorpos ativáveis
DK3175706T3 (en) 2013-09-23 2019-03-04 Regeneron Pharma Non-human animals with a humanized signal regulatory protein gene
SMT201900177T1 (it) 2013-10-15 2019-05-10 Regeneron Pharma Animali con il-15 umanizzata
SG10201811701YA (en) 2013-11-19 2019-01-30 Regeneron Pharma Non-human animals having a humanized a proliferation-inducing ligand gene
CN105792646B (zh) 2013-11-19 2018-03-02 瑞泽恩制药公司 具有人源化的b细胞活化因子基因的非人动物
ES2794942T3 (es) 2014-04-08 2020-11-19 Regeneron Pharma Animales no humanos que tienen receptores Fc-gamma humanizados
NO2785538T3 (enExample) 2014-05-07 2018-08-04
KR20250096864A (ko) 2014-05-19 2025-06-27 리제너론 파마슈티칼스 인코포레이티드 인간 epo를 발현하는 유전자 변형된 비-인간 동물
HUE048677T2 (hu) 2014-06-19 2020-07-28 Regeneron Pharma Humanizált programozott sejthalál 1 génnel rendelkezõ nem-humán állatok
KR20240055876A (ko) 2014-11-24 2024-04-29 리제너론 파마슈티칼스 인코포레이티드 인간화 cd3 복합체를 발현하는 비인간 동물
KR102617691B1 (ko) 2014-12-05 2023-12-27 리제너론 파마슈티칼스 인코포레이티드 인간화 분화 클러스터 47 유전자를 가진 비인간 동물
NZ731954A (en) 2014-12-09 2024-11-29 Regeneron Pharma Non-human animals having a humanized cluster of differentiation 274 gene
KR20240132525A (ko) 2015-04-06 2024-09-03 리제너론 파아마슈티컬스, 인크. 비인간 동물에서의 인간화 t 세포 매개 면역반응
AU2016358101B2 (en) 2015-11-20 2022-12-01 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized Lymphocyte-activation gene 3
JP6980674B2 (ja) * 2016-02-29 2021-12-15 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. ヒト化tmprss遺伝子を有する齧歯類
KR101693243B1 (ko) * 2016-06-15 2017-01-05 재단법인 한국파스퇴르연구소 인플루엔자 바이러스의 복제에 관여하는 신규 인간 유전자 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2019511918A5 (enExample)
JP2017514501A5 (enExample)
JP2019047818A5 (enExample)
JP2017213006A5 (enExample)
KR102213535B1 (ko) pH-민감성 면역글로불린 서열을 발현하는 비-사람 동물
JP2023072039A (ja) 組織選択的導入遺伝子発現
HRP20231121T1 (hr) Životinje koje nisu ljudi, koje imaju gen za humanizirani protein koji regulira signale
RU2757665C2 (ru) Отличные от человека животные со сконструированным локусом легкой лямбда-цепи иммуноглобулина
JP2018500896A5 (enExample)
RU2017123754A (ru) Не относящиеся к человеку животные, имеющие гуманизированный ген кластера дифференцировки 274
RU2018131152A (ru) Грызуны, характеризующиеся гуманизированным геном tmprss
JP2017521060A5 (enExample)
HRP20200613T1 (hr) Neljudske životinje koje imaju humanizirani gen 1 za programiranu staničnu smrt
JP2015523863A5 (enExample)
HRP20231707T1 (hr) Životinje koje nisu ljudi, koje sadrže humanizirani gen iz diferencijacijske skupine 47
JP6636486B2 (ja) ヒト化ジペプチジルペプチダーゼiv(dpp4)動物
JP2020515292A5 (enExample)
FI3823443T3 (fi) Ditra-taudin jyrsijämallit ja niiden käyttö
RU2016143376A (ru) ЖИВОТНЫЕ С ГУМАНИЗИРОВАННЫМИ IL-4 И IL-4Rα
KR102487839B1 (ko) 조작된 angptl8 유전자를 갖는 비인간 동물
JP2019505216A5 (enExample)
JP2020515248A5 (enExample)
JP2016172780A5 (enExample)
Baust et al. Insertional polymorphisms of ETn retrotransposons include a disruption of the wiz gene in C57BL/6 mice.
Jiang et al. Hearing restoration by gene replacement therapy for a multisite-expressed gene in a mouse model of human DFNB111 deafness